Poland· PL-100477796

Livmarli

A maralixibat chloride product containing maralixibatum, registered in Poland by Mirum Pharmaceuticals International B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC A05AX04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLivmarliATCA05AX04REGISTER NO.PL-100477796PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Maralixibat chloride is registered in 11 of 19 countries.

Countries holding a registration under ATC A05AX04 (maralixibat chloride), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Maralixibat chloride · ATC A05AX04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Maralixibatum
Manufacturer
Mirum Pharmaceuticals International B.V.
Country
Poland (PL)
ATC code
A05AX04
ATC class
Maralixibat chloride
Defined daily dose
28.5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    08720696500012
  • gtin
    04150183772600

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0768dca1-cacf-4fec-907c-b27b384593a6
GET /v1/drugs/0768dca1-cacf-4fec-907c-b27b384593a6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór doustny",
  "source": "urpl",
  "strength": "9,5 mg/ml",
  "packaging": "08720696500012 ¦ Rpz ¦ EU/1/22/1704/001 ¦ 148202\n1 butelka 30 ml ¦ 3 strzykawki doustne \n¦ UR/Z/4b/116/24 - 08720696500012 ¦ UR/Z/4b/188/24 - 08720696500012 ¦ UR/Z/4b/080/24 - 08720696500012 ¦ UR/Z/4b/010/23 - 04150183772600 ¦ UR/Z/4b/152/23 - 08720696500012 ¦ UR/Z/4b/184/24 - 08720696500012 ¦ UR/Z/4b/010/25 - 08720696500012 ¦ UR/Z/4b/232/25 - 08720696500012 ¦ UR/Z/4b/008/26 - 08720696500012 ¦ UR/Z/4b/038/26 - 08720696500012 ¦ UR/Z/4b/111/23 ¦ UR/Z/4b/148/26 - 08720696500012 ¦ UR/Z/4b/168/26 - 08720696500012",
  "substance": "Maralixibati chloridum 9.5 mg/ml",
  "common_name": "Maralixibatum",
  "pl_product_id": "100477796",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about maralixibat chloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.